Guanylyl cyclase C is a specific marker for differentiating primary and metastatic ovarian mucinous neoplasms.
OBJECTIVE
The aim was to assess the value of GCC in distinguishing primary ovarian mucinous neoplasms from metastatic mucinous adenocarcinomas with ovarian involvement. Guanylyl cyclase C (GCC) is a brush border membrane receptor for the endogenous peptides guanylin and uroguanylin, and the homologous diarrhoeagenic bacterial heat-stable enterotoxins that is selectively expressed by epithelial cells from the duodenum to the rectum, but not by normal epithelia of the stomach or oesophagus, or normal extramucosal cells in humans.


RESULTS
Fifty ovarian tumours: 27 primary ovarian mucinous neoplasms (seven cystadenomas, 10 borderline tumours and 10 cystadenocarcinomas) and 23 metastatic mucinous adenocarcinomas with ovarian involvement [13 colorectal adenocarcinomas, four gastric adenocarcinomas, six appendiceal mucinous tumours (four adenocarcinomas, one with neuroendocrine features, and two appendiceal mucinous cystadenomas)] were studied. For primary ovarian mucinous neoplasms, 25 of 27 were negative for GCC. Twelve of 13 cases of colorectal adenocarcinoma (except for one neuroendocrine adenocarcinoma) were positive for GCC. Three of four appendiceal mucinous adenocarcinomas were positive for GCC in both the primary and metastatic tumours (except for one neuroendocrine adenocarcinoma). Two of two appendiceal mucinous cystadenomas were positive for GCC. Of four cases of gastric adenocarcinoma with ovarian involvement, only one (primary tumour) exhibited focal GCC staining.


CONCLUSIONS
GCC is a useful marker for differentiating between primary and secondary ovarian mucinous neoplasms.
Ciocca
Vincenzo
V
Department of Pathology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
Bombonati
Alessandro
A
Palazzo
Juan P
JP
Schulz
Stephanie
S
Waldman
Scott A
SA
D002288:Adenocarcinoma, Mucinous / Q000473:pathology / Q000556:secondary; D000328:Adult; D000368:Aged; D001063:Appendiceal Neoplasms / Q000473:pathology; D014408:Biomarkers, Tumor; D015179:Colorectal Neoplasms / Q000473:pathology; D003536:Cystadenocarcinoma / Q000556:secondary; D018291:Cystadenoma, Mucinous / Q000556:secondary; D005260:Female; D006162:Guanylate Cyclase / Q000378:metabolism*; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000473:pathology / Q000556:secondary; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled; D018000:Receptors, Peptide / Q000378:metabolism*; D012189:Retrospective Studies; D013274:Stomach Neoplasms / Q000556:secondary; D047368:Tumor Burden
D014408:Biomarkers, Tumor; D018000:Receptors, Peptide; D006162:Guanylate Cyclase; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled
Virchows Arch. 2003 Dec;443(6):782-6
14576939
Gastroenterology. 2000 Jul;119(1):89-96
10889158
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2695-9
12594332
Am J Surg Pathol. 1997 Oct;21(10):1144-55
9331286
Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7846-51
11438734
Cell. 1990 Nov 30;63(5):941-8
1701694
Mod Pathol. 2005 Jan;18(1):19-25
15389251
Am J Surg Pathol. 2006 Sep;30(9):1130-9
16931958
Proc Natl Acad Sci U S A. 1992 Feb 1;89(3):947-51
1346555
J Anat. 1994 Apr;184 ( Pt 2):407-17
8014132
J Biol Chem. 1991 Sep 25;266(27):17912-8
1680854
Mod Pathol. 2006 Nov;19(11):1421-8
16980943
Am J Surg Pathol. 2003 Jul;27(7):985-93
12826891
Am J Surg Pathol. 2003 Mar;27(3):281-92
12604884
Int J Gynecol Pathol. 2006 Jan;25(1):83-9
16306790
Am J Physiol. 1983 Oct;245(4):G492-8
6312810
Hum Pathol. 2005 Feb;36(2):170-9
15754294
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14827-32
8962140
Mod Pathol. 2000 Sep;13(9):962-72
11007036
Cancer Res. 2000 Sep 15;60(18):5151-7
11016642
Am J Surg Pathol. 1999 Jun;23(6):617-35
10366144
Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10464-8
7902563
Mod Pathol. 2006 Jan;19(1):97-105
16294196